Monoclonal antibody 'cocktail' halts Zika infection

October 4, 2017
Zika virus particles (red) shown in African green monkey kidney cells. Credit: NIAID

A collaborative study led by a University of Miami Miller School of Medicine researcher has found that a "cocktail" of monoclonal antibodies prevented Zika virus (ZIKV) infection in primates. "This is a promising intervention to prevent and treat ZIKV infection during pregnancy," said David Watkins, Ph.D., professor and vice chair for research, Department of Pathology. "We would like to develop this antibody combination and get it into clinical trials as soon as possible."

Watkins and Dennis Burton, Ph.D., chairman and professor of the Department of Immunology & Microbiology at the Scripps Research Institute, led the collaborative international study, "Neutralizing Human Monoclonal Antibodies Prevents Zika Virus Infection in Macaques," published recently in Science Translational Medicine. Miller School co-authors included Diogo M. Magnani, Ph.D., associate scientist and co-first author of the study; Ronald C. Desrosiers, Ph.D., professor of pathology and director of research faculty development; Michael J. Ricciardi, Varian K. Bailey, Lucas Gonzalez-Nieto, Martin J. Gutman, Núria Pedreño-Lopez, Helen S. Maxwell, Aline Domingues, and Mauricio A. Martins, Ph.D., all in the Department of Pathology.

"ZIKV infection is a serious, ongoing public health threat to South Florida, the Caribbean, Latin America and other regions around the world," Watkins said. "If a Zika outbreak occurs in a metropolitan area like Miami, the only way to prevent infection is to avoid the Aedes aegypti mosquitoes that carry the .

Therapies to prevent maternal Zika virus infection and its subsequent fetal developmental complications are urgently required."

Working closely with Burton and Tom Rogers, M.D., Ph.D., from the Scripps Research Institute in La Jolla, California, Watkins' laboratory team used a cocktail of three monoclonal antibodies to treat four monkeys. These three potent ZIKV-neutralizing - called SMZAb1, SMZAb2, and SMZAb5 - were isolated by the Burton group from a South American patient.

Infographic explaining the global prevalence of Zika virus. Credit: Carla Schaffer / AAAS

"We administered a cocktail of these three antibodies to nonhuman primates one day before challenging them with Zika virus that had been isolated from a pregnant woman during the 2016 epidemic in Rio de Janeiro," he said. "To our surprise, this prophylactic treatment completely prevented the virus from taking hold in the animals."

In four control animals, the virus caused a fulminant that lasted for seven days, Watkins added. But there were no measurable virus levels in the blood of the four animals treated with the monoclonal combination, nor was there any immune system response, indicating the virus had been blocked completely.

"Since these have exceptional safety profiles in humans and cross the placenta, this combination could be rapidly developed to protect uninfected pregnant women and their fetuses," he said.

Explore further: Prior dengue or yellow fever exposure does not worsen Zika infection in monkeys

More information: D.M. Magnani el al., "Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aan8184

Related Stories

Prior dengue or yellow fever exposure does not worsen Zika infection in monkeys

August 4, 2017
Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

Early study finds antibody that 'neutralizes' Zika virus

November 7, 2016
Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis, Missouri, have isolated a human monoclonal antibody that in a mouse model "markedly reduced" infection by the ...

CDC shutters command center for Zika monitoring

October 3, 2017
With Zika waning in the Caribbean and South America, the Centers for Disease Control and Prevention announced on Friday that the federal agency was deactivating the command center for monitoring and coordinating emergency ...

Antibody protects against Zika and dengue, mouse study shows

September 25, 2017
Brazil and other areas hardest hit by the Zika virus - which can cause babies to be born with abnormally small heads - are also home to dengue virus, which is spread by the same mosquito species.

A human bi-specific antibody against Zika virus with high therapeutic potential

September 22, 2017
The journal Cell today published data with a bi-specific antibody against Zika virus infection. The article is titled "A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential."

Zika monkey study suggests worse fetal effects for vaginal versus mosquito transmission

August 24, 2017
Rhesus macaques that were vaginally infected with Zika virus showed higher prevalence of Zika in the reproductive tract than previously seen in macaques that received skin injections of the virus. The findings, published ...

Recommended for you

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.